Evolent Health EVH
NYSE EVH
$3.47 +0.07 (+2.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Evolent Health (EVH) Cost of Revenue (2015 - 2026)

Updated

Evolent Health's Cost of Revenue was $571.68 million in Q2 2026, up 66.2% from $343.94 million a year earlier and up 38.6% from the prior quarter.

Analysis

Evolent Health (EVH) Cost of Revenue (2015 - 2026) Analysis & Trends

On a trailing twelve-month basis, Evolent Health's Cost of Revenue was $1.74 billion through Jun 30, 2026, down 5.5% year-over-year; for FY2025, it was $1.48 billion, down 32.5% from FY2024.

  • Cost of Revenue shows a five-year compound annual growth rate of 16.2% (FY2020 to FY2025).
  • In earlier years, Cost of Revenue was $2.19 billion in FY2024 (+45.5%), $1.5 billion in FY2023 (+45.2%), $1.04 billion in FY2022 (+57.5%) and $657.55 million in FY2021 (-5.6%).
  • The Q2 2026 figure marks the highest quarterly Cost of Revenue in data going back to Q2 2015.
  • Compared with a year earlier, Cost of Revenue was higher in four of the last eight quarters, with growth averaging 1.3%.
  • The best year-over-year quarter for Cost of Revenue over five years was Q4 2022 (growth of 82.0%); the worst was Q2 2025 (a decline of 36.3%).
  • Per Business Quant data, EVH's Cost of Revenue in the three quarters before Q2 2026 was $412.47 million (Q1 2026), $371.47 million (Q4 2025) and $379.76 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Evolent Health Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=EVH&period=max&api_key=YOUR_API_KEY